Full-Time

Site Activation Manager

Posted on 5/20/2026

Syneos Health

Syneos Health

10,001+ employees

Global provider of integrated clinical-to-commercial services

No salary listed

Morrisville, NC, USA

Hybrid

West Coast preferred; up to 25% travel; hybrid work arrangement.

Category
Medical, Clinical & Veterinary (1)
Required Skills
Risk Management
Requirements
  • Bachelor’s Degree; Higher Degree Preferred.
  • Minimum 6 years CRO industry experience and/or a minimum 5 years’ experience working in a Site Start-Up, or clinical trial environment or an equivalent combination of education and experience that gives the individual the necessary knowledge, skills and abilities to perform the job.
  • Excellent understanding of clinical trial process across Phases II-IV and ICH Good Clinical Practice.
  • Good understanding clinical protocols and associated study specifications.
  • Excellent understanding of clinical trial start-up processes.
  • Project management experience in a fast-paced environment.
  • Good vendor management skills.
  • Strong organizational skills with proven ability to handle multiple projects.
  • Excellent communication, presentation and interpersonal skills.
  • Quality-driven in all managed activities.
  • Strong negotiating skills.
  • Strong problem-solving skills.
  • Demonstrate an ability to provide quality feedback and guidance to peers.
  • Minimal travel may be required (up to 25%).
Responsibilities
  • Collaborates with major functional areas including, but not limited to: Business Development, Alliance Management, Contracts and Proposals Development, SSU Country Managers, Project Management, Clinical, Data Management and Medical Writing.
  • Identifies and evaluates fundamental issues pertaining to Site Start-Up, project regulatory pathway, successful patient enrollment, interpret data on complex issues, make good business decisions, and ensure solutions are implemented.
  • Ensures all project deliverables meet the internal and customers’ expectations as per contracted deliverables, providing accurate projections, reports and updates, and ongoing risk identification, mitigation and management.
  • Develops and maintains relationships with customers in alignment with their assigned projects.
  • Ensures that individual project targets and client needs are met, services are provided with the highest quality standards, and policies and procedures are followed.
  • Provides oversight of all project start-up deliverables which encompasses all activities from site selection through site activation ready and into the life cycle maintenance of projects.
  • Assumes accountability on start-up deliverables including, but not limited to: Site Identification and selection; Start-up and life cycle maintenance regulatory activities (submissions, oversight of communication to competent authorities/ethics committees, import/export licenses and extensions, study maintenance and amendment submissions); Oversight of delivery of executed clinical trial agreements and investigator budgets with investigator sites, including any require amendments; Establishing and overseeing Essential Document collection leading to site activation; Overall SSU timelines, prior to and following site activation. Including any realignment required due to amendment needs.
  • Develops plans in accordance with Standard Operating Procedures and/or sponsor-scoped processes. Complies all controlled document requirements and other requirements to ensure quality deliverables.
  • Develops and manages integrated site start-up timelines and reports weekly progress including plans to address potential timing risks/gaps.
  • Prepares and presents overall SSU strategy and status at client meetings and communicates outcomes to project team.
  • Reviews the project SSU budget with the functional leads, PM, and the SSU Business Unit Controller against project milestones and budget to ensure project profitability. Takes corrective measures where necessary to keep projects in line with budget and gross profit expectations.
  • Uses professionally recognized tools for planning and management of scope, timeline, and resources and ensures effective budget management. If out-of-scope work is requested, notifies the PM and SSU Manager and tracks out-of-scope work until it is assigned to back log.
  • Prepares the core submission documents and core clinical trial application dossier for amendments during life cycle maintenance of the projects.
  • Performs a Regulatory Impact Assessment on core amendment submission documents and communicates any risk mitigation to Sponsor/Project teams and oversees review for Regulatory Impact Assessment for 2nd level to identify gaps, highlights any risk management to Sponsor/Project teams.
  • Responsible for or assists in initial or amendment updated development of master Subject Information Sheet (SIS) /Informed Consent Form (ICF) in collaboration with the PM and Medical Department.
  • Oversees collation, quality review, and submission of country-specific applications.
  • Contributes to change initiatives across and within the SSU department.
  • Ensure all relevant documents are submitted to the Trial Master File (TMF) as per Company SOP/Sponsor requirements.
  • Performs other work-related duties as assigned. Minimal travel may be required (up to 25%).

Syneos Health provides end-to-end biopharmaceutical solutions across the clinical-to-commercial spectrum. It helps biopharma companies, healthcare organizations, and investors by offering specialized expertise, insights, and technology-enabled services to move therapies faster to patients. Its offerings include Kinetic, a modern omnichannel customer engagement platform that uses targeting and analytics to coordinate nationwide healthcare communications, and Syneos One, an asset development approach that aligns strategy and execution from early concept through commercialization. The company uses AI and advanced tech to improve performance and reduce risk in drug development and market delivery. Its goal is to be a trusted partner that accelerates therapy development and delivery by combining scientific know-how with integrated, data-driven services.

Company Size

10,001+

Company Stage

IPO

Headquarters

Morrisville, North Carolina

Founded

1985

Your Connections

People at Syneos Health who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Pharma spends 30-50% of revenue on field teams, creating optimization demand.
  • AI-driven commercial analytics can improve launch performance and deepen client lock-in.
  • Global partnerships and acquisitions expand Syneos' reach across diagnostics, China, and Malaysia.

What critics are saying

  • AI conversation intelligence faces privacy and rep-consent objections, slowing enterprise rollout.
  • Domestic CROs in China undercut Bestudy-linked margins and crowd out foreign-backed vendors.
  • HelioLiver adoption risk remains high if physicians ignore reimbursement and field education efforts.

What makes Syneos Health unique

  • Syneos spans preclinical development through full commercialization and marketing capabilities.
  • KAI integration strengthens field execution with conversation intelligence and next-best-action coaching.
  • HelioLiver launch experience showcases specialty-diagnostic education across hepatology and gastroenterology networks.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Employee Stock Purchase Plan

Flexible Work Hours

Paid Vacation

Paid Sick Leave

Remote Work Options

Company News

Fierce Biotech
Mar 19th, 2026
Syneos Health scoops up Chinese CRO to secure place in ‘rapidly growing market’

North Carolina-based contract research organization Syneos Health is making a play to capitalize on China’s rapidly ascendant biopharma industry. | North Carolina-based contract research organization Syneos Health is making a play to capitalize on China’s rapidly ascendant biopharma industry. Syneos has acquired Chinese CRO Bestudy to secure a foothold in the Asian nation.

PRWeek
May 7th, 2025
Imre hires Greg Voyles as chief growth officer

Voyles joins Imre from Syneos Health, where he served as VP of commercial solutions.

Healthcare Asia Magazine
Dec 2nd, 2024
Sunway Healthcare Group, Syneos Health to expand clinical trial expertise

Sunway Healthcare Group has partnered with Syneos Health to expand clinical trial capabilities across therapeutic areas in Malaysia.

BioSpace
Oct 10th, 2024
Syneos Health Appoints Costa Panagos as Chief Executive Officer

Syneos Health appoints Costa Panagos as chief executive officer.

PRWeek
Oct 7th, 2024
Syneos Health makes senior hires

Syneos has also appointed Jen Husdan as an associate director.

INACTIVE